NEW YORK, Sept. 26, 2018 /PRNewswire/ -- About Endometrial CancerEndometrial cancer is a type of uterine cancer, which begins in the layer of cells that form the lining (endometrium) of the uterus of women. Unopposed endometrial estrogen exposure such as estrogen replacement therapy during menopause is associated with increased risk of developing endometrial cancer among women.Read the full report: https://www.reportlinker.com/p05570396
Technavio's analysts forecast the Global Endometrial Cancer Therapeutics Market to grow at a CAGR of 5.17% during the period 2018-2022.Covered in this reportThe report covers the present scenario and the growth prospects of the endometrial cancer therapeutics market. To calculate the market size, the report considers the revenue generated by treatment of endometrial cancer across the globe.The market is divided into the following segments based on geography:• Americas• APAC• EMEATechnavio's report, endometrial cancer therapeutics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.Key vendors• CELGENE• Janssen Pharmaceuticals• Novartis• Pfizer• Teva Pharmaceutical IndustriesMarket driver• Increasing prevalence of endometrial cancer• For a full, detailed list, view our reportMarket challenge• High cost associated with treatment• For a full, detailed list, view our reportMarket trend• Immune therapy• For a full, detailed list, view our reportKey questions answered in this report• What will the market size be in 2022 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key vendors?• What are the strengths and weaknesses of the key vendors?You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.Read the full report: https://www.reportlinker.com/p05570396
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected]
US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
View original content:http://www.prnewswire.com/news-releases/global-endometrial-cancer-therapeutics-market-2018-2022-300719438.html
SOURCE Reportlinker
